Benefits, efficacy, cost-effectiveness and infectious complications in transplant patients desensitized with intravenous immunoglobulin and anti-CD20 therapy

Benefits of Rituximab Combined With Intravenous Immunoglobulin for Desensitization in Kidney Transplant Recipients

(2014) Ashley A. Vo et al.   TRANSPLANTATION

Regulatory B Cells: An Exciting Target for Future Therapeutics in Transplantation

(2014) Alexandre Nouël et al.   Frontiers in Immunology

Cryptic B Cell Response to Renal Transplantation

(2013) R. J. Lynch et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Reduced T-Dependent Humoral Immunity in CD20-Deficient Mice

(2013) D. E. D. Morsy et al.   JOURNAL OF IMMUNOLOGY

Efficacy, Outcomes, and Cost-Effectiveness of Desensitization Using IVIG and Rituximab

(2013) Ashley A. Vo et al.   TRANSPLANTATION

Rituximab Prevents an Anamnestic Response in Patients With Cryptic Sensitization to HLA

(2013) Andrea A. Zachary et al.   TRANSPLANTATION

Analysis of Anti-HLA Antibodies in Sensitized Kidney Transplant Candidates Subjected to Desensitization with Intravenous Immunoglobulin and Rituximab

(2013) Andrew L. Lobashevsky et al.   TRANSPLANTATION

B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells

(2012) Tom A. Barr et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Antibody-mediated vascular rejection of kidney allografts: a population-based study

(2012) Carmen Lefaucheur et al.   LANCET

The impact of donor-specific anti-HLA antibodies on late kidney allograft failure

(2012) Alexandre Loupy et al.   Nature Reviews Nephrology

Lack of Effect in Desensitization With Intravenous Immunoglobulin and Rituximab in Highly Sensitized Patients

(2012) Kwaku Marfo et al.   TRANSPLANTATION

Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity

(2012) Henrik E Mei et al.   ARTHRITIS RESEARCH & THERAPY

Chronic Antibody-Mediated Rejection Is Reduced by Targeting B-Cell Immunity During an Introductory Period

(2011) N. Kohei et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Summary of FDA Antibody-Mediated Rejection Workshop

(2011) P. Archdeacon et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Desensitization Protocols and Their Outcome

(2011) K. Marfo et al.   Clinical Journal of the American Society of Nephrology

Desensitization in HLA-Incompatible Kidney Recipients and Survival

(2011) Robert A. Montgomery et al.   NEW ENGLAND JOURNAL OF MEDICINE

Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation

(2010) C. Lefaucheur et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Advances in diagnosing and managing antibody-mediated rejection

(2010) Stanley C. Jordan et al.   PEDIATRIC NEPHROLOGY

Combined Posttransplant Prophylactic IVIg/Anti-CD 20/Plasmapheresis in Kidney Recipients With Preformed Donor-Specific Antibodies: A Pilot Study

(2010) Alexandre Loupy et al.   TRANSPLANTATION

Use of Intravenous Immune Globulin and Rituximab for Desensitization of Highly HLA-Sensitized Patients Awaiting Kidney Transplantation

(2010) Ashley A. Vo et al.   TRANSPLANTATION

CD20 deficiency in humans results in impaired T cell–independent antibody responses

(2009) Taco W. Kuijpers et al.   JOURNAL OF CLINICAL INVESTIGATION

The Use of Immunoglobulin Therapy for Patients Undergoing Solid Organ Transplantation: An Evidence-Based Practice Guideline

(2009) Nadine Shehata et al.   TRANSFUSION MEDICINE REVIEWS

The Spectrum of Antibody-Mediated Renal Allograft Injury: Implications for Treatment

(2008) J. Gloor et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation

(2008) Ashley A. Vo et al.   NEW ENGLAND JOURNAL OF MEDICINE